Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Neuromolecular Med. 2019 May 4;21(4):325–343. doi: 10.1007/s12017-019-08537-7

Table 1.

Genetic Syndromes, underlying defective gene, and IA Incidence

Syndrome Major Gene(s) IA incidence References
Autosomal Dominant Polycystic Kidney Disease (ADPKD) PKD1, PKD2 11% (Cagnazzo et al. 2017)
Type IV Ehlers-Danlos Syndrome (Vascular Subtype) Col3a1 17.5% (S. T. Kim et al. 2016)
Microcephalic/Majewski’s Osteodysplastic Primordial Dwarfism, Type II (MOPD2) PCNT up to 50% (Teo et al. 2016; Bober et al. 2010; Brancati et al. 2005; Li et al. 2015)
Loeys-Dietz Syndrome (LDS) TGFBR1, TGFBR2, SMAD3, TGFB2 10-28% (Loeys et al. 2006; Rodrigues et al. 2009; Vanakker et al. 2011; S. T. Kim et al. 2016)
Marfan Syndrome FBN1 0-14% (van den Berg et al. 1996; Conway et al. 1999; S. T. Kim et al. 2016)
Neurofibromatosis Type I NF1 9% (Conway et al. 2001; Schievink et al. 2005)